Disclosures for "Characterization of a Novel Repeat-dosing Model for Preclinical Diazepam Studies"
-
Dr. Guignet has received research support from Neurelis Inc. .
-
Dr. Shih has received personal compensation for serving as an employee of Neurelis, Inc.. The institution of Dr. Shih has received research support from Cerebral Palsy Alliance Research Foundation. Dr. Shih has received publishing royalties from a publication relating to health care.
-
Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Neurelis, Alexza, Zogenix. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences. Enrique Carrazana has stock in Neurelis, Marinus, .
-
Dr. Rabinowicz has received personal compensation for serving as an employee of Neurelis, Inc. Dr. Rabinowicz has stock in Neurelis, Inc.